Clinical trial
Anti-Oxidant Therapy In Chronic Renal Insufficiency (ATIC) Study
NCT00384618 · Amsterdam UMC, location VUmc, Other · Terminated
Key facts
| NCT number | NCT00384618 |
|---|---|
| Title | Anti-Oxidant Therapy In Chronic Renal Insufficiency (ATIC) Study |
| Official title | Effect of an Oxidative-Stress-Reducing Strategy Consisting of Pravastatin, Vitamin E and Homocysteine-Lowering on Carotid Intima-Media Thickness in Patients With Mild-to-Moderate Chronic Kidney Disease |
| Lead sponsor | Amsterdam UMC, location VUmc, Other |
| Collaborators | Medical Research Foundation, The Netherlands Bristol-Myers Squibb Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease |
| Intervention type | Drug |
| Interventions | pravastatin, vitamin E |
| Enrollment | 100 |
| Start date | May 1, 2001 |
| Completion | Aug 1, 2005 |
| First posted | Oct 6, 2006 |
| Last update posted | Oct 6, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: